Merck gets a patent win for muscle relaxant reversal drug
Merck won a patent lawsuit that allows it to keep marketing a blockbuster surgery drug until early 2026.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
